Effects of propyphenazone and other non-steroidal anti-inflammatory agents on the synthetic and endogenous androgenic anabolic steroids urinary excretion and/or instrumental detection

Analytica Chimica Acta

Volumn 657, Issue 1, 2010, Pages 60-68

  Mazzarino, Monica ^a   Braganò, Maria Cristina ^a   Donati, Francesco ^a   de la Torre, Xavier ^a   Botrè, Francesco ^a,b  

^a Laboratorio Antidoping   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Androgenic anabolic steroids; Anti doping analysis; Derivatization; Gas chromatography mass spectrometry; NSAID

Indexed keywords

ANDROGENIC ANABOLIC STEROIDS; ANDROSTANE; ANTI-INFLAMMATORY AGENTS; DEHYDROEPIANDROSTERONE; DERIVATIZATIONS; DOPING ANALYSIS; ETIOCHOLANOLONE; INSTRUMENTAL DETECTION; NON-STEROIDAL ANTI-INFLAMMATORY DRUGS; ORAL ADMINISTRATION; SAMPLE PREPARATION; SINGLE-DOSE; URINARY EXCRETION; URINE SAMPLE;

BIOMOLECULES; BODY FLUIDS; CHROMATOGRAPHIC ANALYSIS; CONTROLLED DRUG DELIVERY; DRUG PRODUCTS; GAS CHROMATOGRAPHY; LIPIDS; METABOLISM; METABOLITES; SPECTROMETRY;

DRUG DOSAGE;

11KETOETIOCHOLANOLONE; 5BETA ANDROSTAN 11BETA OL 17 ONE; 5BETA ANDROSTANE 3ALPHA,17BETA DIOL; 5BETA ANDROSTANE DERIVATIVE; ANABOLIC AGENT; ANDROGEN; ANDROSTANEDIOL; ANDROSTERON 11BETA OL; ANDROSTERONE; CISTALGAN; DICLOFENAC; EPITESTOSTERONE; ETIOCHOLANOLONE; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PRASTERONE; PROPYPHENAZONE; TESTOSTERONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DERIVATIZATION; DOSE RESPONSE; HUMAN; HYDROLYSIS; MALE; MASS FRAGMENTOGRAPHY; PRIORITY JOURNAL; SINGLE DRUG DOSE; STEROID EXCRETION; STEROID URINE LEVEL; URINALYSIS; URINARY EXCRETION;

ANABOLIC AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG INTERACTIONS; EPITESTOSTERONE; HUMANS; MALE; REFERENCE STANDARDS; STEROIDS; SUBSTANCE ABUSE DETECTION; TESTOSTERONE;

EID: 70749140187     PISSN: 00032670     EISSN: 18734324     Source Type: Journal    
DOI: 10.1016/j.aca.2009.10.022     Document Type: Article

References (22)

1. Mareck U., Geyer H., Opfermenn G., Thevis M., and Schänzer W. Factors influencing the steroid profile in doping control analysis. J. Mass Spectrom. 43 (2008) 877-891
2. de Boer D., Van Schaik L., Waasdorp T.J.A., and Maes R.A.A. The influence of propyphenazone on the excretion of steroids. In: Donike M., Geyer H., Gotzmann A., Mareck -Engelke U., and Rauth S. (Eds). Recent Advances in Doping Analysis (1), Köln (Germany) (1993) 91-96
3. The World Anti-Doping Code, The 2009 Prohibited List International Standard, World Anti-Doping Agency, Montreal, Canada, 2009, Available from: www.wada-ama.org.
4. Leadbetter W.B. Anti-inflammatory therapy in sports injury: the role of nonsteroidal drugs and corticosteroid injections. Clin. Sports Med. 14 2 (1995) 353-410
5. L.C. Almekinders, Nonsteroidal anti-inflammatory drugs and corticosteroids, in: Di Michael S. Bahrke, Charles Yesalis (Eds.), Performance-enhancing substances in sport and exercise, Chapter 12, pp. 125-213.
6. Di Luigi L., Rossi C., Sgrò P., Fierro V., Romanelli F., Baldari C., and Guidetti L. Do non-steroidal anti-inflammatory drugs influence the steroid hormone milieu in male athletes?. Int. J. Sports Med. 28 10 (2007) 809-814
7. Conte D., Romanelli F., Fillo S., Guidetti L., Isidori A., Franceschi F., Latini M., and Di Luigi L. Aspirin inhibits androgen response to chorionic gonadotropin in humans. Am. J. Physiol. 277 (1999) E1032-E1037
8. Di Luigi L., Guidetti L., Romanelli F., Baldari C., and Conte D. Acetylsalicylic acid inhibits the pituitary response to exercise-related stress in humans. Med. Sci. Sports Exerc. 33 (2001) 2029-2035
9. Przybylowski J., Obodynski K., Lewicki C., Kuzniar J., Zaborniak S., Drozd S., Czarny W., and Garmulewicz M. The influence of aspirin on exercise-induced changes in adrenocorticotrophic hormone (ACTH), cortisol and aldosterone (ALD) concentrations. Eur. J. Appl. Physiol. 89 (2003) 177-183
10. Ayotte C., Charlebois A., Lapointe S., Barriault D., and Sylvestre M. Validity of urine sample microbial degradation. In: Schänzer W., Geyer H., Gotzmann A., and Mereck-Engelke U. (Eds). Recent Advances in Doping Analysis (4) (1996), Sport und Buch Strauβ, Köln (Germany) 127-138
11. Hemmersbach P., Birkeland K.I., Norli H.R., and Ringertz S.H. Urine storage conditions and steroid profile analysis. In: Schänzer W., Geyer H., Gotzmann A., and Mereck-Engelke U. (Eds). Recent Advances in Doping Analysis (4) (1996), Sport und Buch Strauβ, Köln (Germany) 99-105
12. de la Torre R., de la Torre X., Segura J., Smeyers M.T., Ventura R., Torres J.M., Alia C., and Barò T. Urine contamination by micro-organism and alterations in the endogenous steroid profile, A prospective study. In: Schänzer W., Geyer H., Gotzmann A., and Mereck-Engelke U. (Eds). Recent Advances in Doping Analysis (6) (1998), Sport und Buch Strauβ, Köln (Germany) 223-234
13. Molaioni F., Abate M.G., Alocci R., Mazzarino M., Rossi F., and Botrè F. Urine stability, steroid profile and T/E ratio: towards an index of sample degradation. In: Schänzer W., Geyer H., Gotzmann A., and Mareck U. (Eds). Recent Advances in Doping Analysis (13) (2005), Sportverlag Strauß, Köln (Germany) 179-188
14. World Anti-Doping Agency: WADA Technical Document-TD2004 EAAS. Reporting and evaluation guidance for testosterone, epitestosterone, T/E ratio and other endogenous steroids, Available from: http://www.wada-a.org/rtecontent/document/end_steroids_aug_04.pdf (accessed 01.04.07).
15. Mazzarino M., Rossi F., Giacomelli L., and Botrè F. Effect of the systemic vs. inhalatory administration of synthetic glucocorticoids on the urinary steroid profile as studied by Gas Chromatography-Mass Spectrometry. Anal. Chim. Acta 559 (2006) 30-36
16. Leinonen A., Kuuranne T., Moisander T., and Rautava K. Artificial urine as sample matrix for calibrators and quality controls in determination of testosterone to epitestosterone ratio. In: Schänzer W., Geyer H., Gotzmann A., and Mareck U. (Eds). Recent Advances in Doping Analysis (15) (2007), Sportverlag Strauß, Köln (Germany) 401-404
17. Donike M. Steroid profile in Cologne. In: Donike M., Geyer H., Gotzmann A., Mereck-Engelke U., and Rauth S. (Eds). Recent Advances in Doping Analysis (0) (1992), Sport und Buch Strauβ, Köln (Germany) 47-68
18. Mareck-Engelke U., Geyer H., and Donike M. Stability of steroid profiles (2): excretion rates from morning urines. In: Donike M., Geyer H., Gotzmann A., Mereck-Engelke U., and Rauth S. (Eds). Recent Advances in Doping Analysis (1) (1993), Sport und Buch Strauβ, Köln (Germany) 85-90
19. Mareck-Engelke U., Geyer H., and Donike M. Stability of steroid profiles (3): ratios and excretion rates of endogenous steroids in male urines collected over 24 hours. In: Donike M., Geyer H., Gotzmann A., Mereck-Engelke U., and Rauth S. (Eds). Recent Advances in Doping Analysis (2) (1994), Sport und Buch Strauβ, Köln (Germany) 121-134
20. Volz M., and Kellner H.-M. Kinetic and metabolism of pyrazolones (propyphenazone, aminopyrine and dipyrone) Br. J. Clin. Pharmacol. 10 (1980) 299-330
21. Geyer H., Mereck-Engelke U., Schänzer W., and Donike M. The Cologne protocol to follow up high testosterone/epitestosterone ratios. In: Schänzer W., Geyer H., Gotzmann A., and Mereck-Engelke U. (Eds). Recent Advances in Doping Analysis (4) (1996), Sport und Buch Strauβ, Köln (Germany) 107-126
22. Leinonen A., Savonen L., and Kuoppasalmi K. Improved purification of anabolic steroids for GC/MS-analysis. In: Donike M., Geyer H., Gotzmann A., Mereck-Engelke U., and Rauth S. (Eds). Recent Advances in Doping Analysis (1) (1993), Sport und Buch Strauβ, Köln (Germany) 25-32